← Back to Patent Explorer
US4577636A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for diagnosis of atherosclerosis

Assignee: Beth Israel Deaconess Medical Center
•
Filing: 1984-01-27
•
Granted: 1986-03-25
•
Expires: 2004-01-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method for diagnosis of the presence of atherosclerosis plaques. The method comprises injection of a hematoporphyrin which is selectively absorbed by atheromotous plaques. The hematoporphyrin is then subjected to light causing it to fluorese and the fluorescence is used to diagnose the presence of the plaques.

Inventors

  • 👤 J. Richard Spears

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 00:32
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61B; A61B17/00; A61B17/22; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B18/245; A61M; A61M29/00; A61M29/02; A61B2017/00681; A61B2017/00694; A61B2017/22038; A61B2017/22051; A61B2017/22057; A61B2017/22059; A61B2017/22082; A61B2017/22085; A61B2017/22087; A61B2018/2255; A61B2018/2261; A61B90/00; A61B90/30; A61B2090/306

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 53 words
A method for diagnosing atherosclerosis, said method comprising: injecting a porphyrin solution into the blood vessels to be examined; detecting the quantity of porphyrins absorbed by tissues in the blood vessels; and contrasting the quantity of porphyrins in different areas of the blood vessels to determine location, size, and quantity of athermatous plaques.
Claim 2
Independent Claim 53 words
A method for diagnosing atherosclerosis, said method comprising: injecting a porphyrin solution into the blood vessels to be examined; detecting the quantity of porphyrins absorbed by tissues in the blood vessels; and contrasting the quantity of porphyrins in different areas of the blood vessels to determine location, size, and quantity of athermatous plaques.
Claim 3
Dependent Claim 10 words
The method of claim 1 wherein the porphyrins are radiolabeled.
Claim 4
Dependent Claim 14 words
The method of claim 1 wherein a radio-opaque material is bound to the porphyrins.
Claim 5
Dependent Claim 13 words
The method of claim 1 wherein a metal is bound to the porphyrin.
Claim 6
Dependent Claim 27 words
The method of claim 1 wherein the preferential absorbtion of porphyrins by atheromatous plaques is detected by illuminating the plaques with ultraviolet light and detecting the fluorescence.
Claim 7
Dependent Claim 21 words
The method of claim 4 wherein the preferential absorbtion of porphyrins by atheromatous plaques is detected by nuclear magnetic resonance spectroscopy.
Claim 8
Dependent Claim 20 words
The method of claim 2 wherein the preferential absorbtion of porphyrins by atheromatous plaques is detected by radionuclide scintillation techniques.
Claim 9
Dependent Claim 15 words
The method of claim 3 wherein the preferential absorbtion of X-rays by porphyrins is detected.
Claim 10
Dependent Claim 17 words
The method of claim 2 wherein the preferential absorbtion of porphyrins is detected by Positron Emission Tomography.
Claim 11
Dependent Claim 21 words
The method of claim 1 wherein an antibody specific for a component of the atheromatous plaques is bound to the porphyrins.

References Cited (Backward Citations)

US3494354A Cited
US3557783A Cited
US3661148A Cited
US4323071A Cited
US4323071B1 Cited
US4266549A Cited
US4315512A Cited
US4336809A Cited
US4384584A Cited
US4459990A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-03-24 1989-09-23 1990-03-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-03-24 1993-09-23 1994-03-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-03-24 1997-09-23 1998-03-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag